SynopsisThe global Drug-Eluting Bioabsorbable Stents market size is expected to reach US$ 1217.4 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Drug-Eluting Bioabsorbable Stents in various e.....
SynopsisImmune globulin (Ig) short-term protection against hepatitis A and measles The global Immune Globulin Intravenous market size is expected to reach US$ 21770 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the .....
SynopsisThe global Surgical Visualization System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devic.....
SynopsisThe global Toilet Assist Devices for Disabled market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Toilet Assist Devices for Disab.....
SynopsisThe global Vertical Medical Cyclotron market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices .....
SynopsisThe global Benchtop Bioreactors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Benchtop Bioreactors is estimated to increase.....
SynopsisIschemic hepatitis is also known as shock liver is a condition affecting 0.18%–0.50% of inpatient admissions per year. Usually, the affected patient has no abdominal pain symptoms and the diagnosis is based on biochemical blood analysis. In ischemic hepatitis .....
SynopsisAn angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. The global Angiotensin Converting Enzyme (ACE) Inhibitors market .....
SynopsisAn essential part of the guided bone & tissue regeneration process, Non-resorbable PTFE Membranes, made of microporous high-density polytetrafluoroethylene (dPTFE) material, are biologically inert and chemically non-reactive, which makes it an ideal choice for.....
SynopsisFenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) .....
